STEFANO BALLESTRI MD - European Association for the Study of

Personal information
Date of Birth: 05.02.1978
Place of Birth: Castelfranco Emilia, Modena
Present Position
Second-year Ph.D. Student
International Doctorate School in Clinical and Experimental Medicine
Course of Hepatogastroenterological, Endocrinological and Immunoallergological Sciences
University of Modena e Reggio Emilia
Department of Medicine, Endocrinology, Metabolism and Geriatrics
Unità Operativa di Medicina ad indirizzo Metabolico - Nutrizionistico
Nuovo Ospedale S. Agostino Estense di Baggiovara – Via Giardini 1355 – Modena (MO)
Contact Information
Tel: 059 -3961809
FAX: 059 - 3961335
Education and academic career
1997: Graduation High School Liceo Scientifico
1997 - 2003: Medical Student at the University of Modena;
2002 - 2003: Internship at the Institute of Internal Medicine directed by Prof. Nicola Carulli
2003: Medical degree at the University of Modena summa cum Laude; thesis on: “Leptin and ghrelin
in NAFLD (Non Alcoholic Fatty Liver Disease). Relationship with insulin-resistance and role in
pathogenesis of the disease”.
2008: Internal Medicine Degree at University of Modena summa cum laude; thesis on “Predictors of
hepatic steatosis and metabolic derangements in patients with viral infection (HIV, HCV e HIVHCV)”.
2008: Winner of scholarship for the Ph.D. School in Clinical and Experimental Medicine, Course of
Hepatogastroenterological, Endocrinological and Immunoallergological Sciences at University of
Modena e Reggio Emilia.
- SIUMB -Società Italiana di Ultrasonologia in Medicina e Biologia
- AISF – Associazione Italiana Studio Fegato
- EASL –European Association for the Study of Liver
Scientific Research (Main Line)
Hepatic steatosis of primary and secondary (HCV, HIV, HIV-HCV) origin
Hepatocellular carcinoma
Main clinical interest:
Metabolic liver diseases
Metabolic Syndrome
Viral liver diseases
Ortotopic liver transplantation
Liver and biliary cancer
In extenso:
1. Loria P, Lonardo A, Carulli L, Verrone Am, Ricchi M, Lombardini S, Rudilosso, A, Ballestri S.,
Carulli N. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
Alimentary Pharmacology And Therapeutics 2005; 22 Suppl 2: 31-36
2. E. Michelini, A. Lonardo, Ballestri S., M. Costantini, C. Caporali, M.E. Bonati, M. Bertolotti, R.
Iori, P. Loria. Is Cholangiocarcinoma Another Complication of Insulin Resistance: A Report of
Three Cases. Metabolic Syndrome And Related Disorders 2007; 5: 194-202.
3. Lonardo A, Lombardini S, Scaglioni F, Ballestri S., Verrone Am, Bertolotti M, Carulli L, Ganazzi
D, Carulli N, Loria P. Fatty liver, carotid disease and gallstones: a study of age-related
associations. World Journal Of Gastroenterology 2006; 12: 5826-583.
4. Ballestri S, Lonardo A, Carulli L, Ricchi M, Bertozzi L, De Santis G, Bondi M, Loria P. The neckliver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic
histology. Hepatology 2008;47:361-2.
5. Loria P, Ballestri S Lonardo A. Gli enzimi epatobiliari nella diagnostica clinica delle epatopatie.
Intern Emerg Med, Medicina Italia 2008; 4.
6. Ballestri S, Lonardo A, Losi L, Pellegrini E, Bertolotti M, Loria P. Do diabetes and obesity
promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? Intern Emerg Med
2009; 4:71–73.
7. Ricchi M, Odoardi MR, Carulli L, Anzivino C, Ballestri S, Pinetti A, Fantoni LI, Marra F,
Bertolotti M, Banni S, Lonardo A, Carulli N and Loria P. Differential effect of oleic and palmitic
acid on lipid accumulation and apoptosis in cultured hepatocytes. J Gastroenterol Hepatol. 2009;
8. Lonardo A, Ballestri S, Adinolfi LE, Violi E, Carulli L, Lombardini S, Scaglioni F, Ricchi M,
Ruggiero G, Loria P. HCV infected patients are “spared” from the metabolic syndrome but not
from insulin resistance. A comparative study of NAFLD and HCV-related steatosis. Can J
Gastroenterol. 2009; 23:273-8.
9. Guaraldi G, Stentarelli C, Orlando G, Zona S, Carli F, Ballestri S, Lonardo A, Squillace N, Loria
P. Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of
nucleoside reverse transcriptase inhibitors. J Acquir Immune Defic Syndr. 2010; 53:278.
10. Ballestri S, Losi L, Favali M, Luppi C, Lami F, Macchioni D, Bertani H, Lonardo A, Loria P.
Hypervascular Retroperitoneal Mass in a Patient with Fever and Leucocytosis – Contrast-Enhanced
Ultrasonographic Findings in a Case of Inflammatory Malignant Fibrous Histiocytoma. Ultraschall
in Med. Ultraschall Med. Published Online First: 20 April 2010.